5-Amino-1MQ

Certificate of Analysis & Complete Test Results

✓ Verified & Certified
Test Date
Jan 30, 2026
Batch Number
110115
Purity Level
99.92%

Certificate of Analysis

High-Performance Liquid Chromatography

Client: Peptides Canada
Sample Name: Tesamorelin
Batch #: 110115
Report Date: 03/25/2025
Test: Purity
Receipt Date: 03/22/2025
Analysis Date: 03/25/2025
Matrix: Powder
Number of samples: 1
Purity: 99.92%

Research-grade specification: ≥95.0% — this batch exceeds specification.

Date File 110115_MS2_posneg_Tesamorelin_Lot110115_purity.d Sample Name Tesamorelin_Lot110115_purity
Sample Type Sample Position P2-29
Instrument Name LCMS-7800 Series Username -
Acq Method purityDefaultR52.m Acquired 03/25/2025 03:31:43 PM
IRM Calibration Status Calibrated Time (UTC-07:00)
Comment Sample test for purity of Tesamorelin batch 110115 DA Method SignalToNoiseCheckout.m
Sample Group Test Batch 5 Info. -
Stream Name LC1 Acquisition 03/25/2025 03:31:43 PM
Acquisition SW Version 6400 Series Triple Quadrupole B.09.00 (89037.0) Time (Local) (UTC-07:00)

Peak List

Time Area % Area
12.42 min 2847.3 99.92 %
16.83 min 31.1 0.08 %

* determined as Tesamorelin based on retention time

Note: Percent area between two compounds is not quantitative due to variable extinction coefficients.

Test Screen

UV Chromatogram:

Identity: Tesamorelin

(Other names: Tesamorelin, Egrifta, Egrifta SV)

CAS: 901758-09-6

Data

Mass Spectrum

MSMS ID — head to tail database matching

Mass Spectrum Protein Envelope encompasses the 3-6 positive change states conferring Peptide Mass

Tesamorelin

Expected Mass: 5139.8

Observed Mass: 5139.8

Reviewed and approved by:

Herman Lelie

Pepslab.ca LLC. All test results are the responsibility of the client. This report relates only to the samples tested. The analyses were performed except as indicated. Samples are within quality control criteria and area specifications unless noted.